Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119072885> ?p ?o ?g. }
- W3119072885 endingPage "e001660" @default.
- W3119072885 startingPage "e001660" @default.
- W3119072885 abstract "Although antibodies blocking immune checkpoints have already been approved for clinical cancer treatment, the mechanisms involved are not yet completely elucidated. Here we used a λ-MYC transgenic model of endogenously growing B-cell lymphoma to analyze the requirements for effective therapy with immune checkpoint inhibitors.Growth of spontaneous lymphoma was monitored in mice that received antibodies targeting programmed cell death protein 1 and cytotoxic T lymphocyte-associated protein-4, and the role of different immune cell compartments and cytokines was studied by in vivo depletion experiments. Activation of T and natural killer cells and the induction of tumor senescence were analyzed by flow cytometry.On immune checkpoint blockade, visible lymphomas developed at later time points than in untreated controls, indicating an enhanced tumor control. Importantly, 20% to 30% of mice were even long-term protected and did never develop clinical signs of tumor growth. The therapeutic effect was dependent on cytokine-induced senescence in malignant B cells. The proinflammatory cytokines interferon-γ (IFN-γ) and tumor necrosis factor (TNF) were necessary for the survival benefit as well as for senescence induction in the λ-MYC model. Antibody therapy improved T-cell functions such as cytokine production, and long-time survivors were only observed in the presence of T cells. Yet, NK cells also had a pronounced effect on therapy-induced delay of tumor growth. Antibody treatment enhanced numbers, proliferation and IFN-γ expression of NK cells in developing tumors. The therapeutic effect was fully abrogated only after depletion of both, T cells and NK cells, or after ablation of either IFN-γ or TNF.Tumor cell senescence may explain why patients responding to immune checkpoint blockade frequently show stable growth arrest of tumors rather than complete tumor regression. In the lymphoma model studied, successful therapy required both, tumor-directed T-cell responses and NK cells, which control, at least partly, tumor development through cytokine-induced tumor senescence." @default.
- W3119072885 created "2021-01-18" @default.
- W3119072885 creator A5000430747 @default.
- W3119072885 creator A5016924764 @default.
- W3119072885 creator A5018760297 @default.
- W3119072885 creator A5030616197 @default.
- W3119072885 creator A5039290647 @default.
- W3119072885 creator A5050472627 @default.
- W3119072885 creator A5069800223 @default.
- W3119072885 creator A5072030436 @default.
- W3119072885 creator A5081250941 @default.
- W3119072885 creator A5084135240 @default.
- W3119072885 creator A5090423715 @default.
- W3119072885 date "2021-01-01" @default.
- W3119072885 modified "2023-10-18" @default.
- W3119072885 title "Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence" @default.
- W3119072885 cites W1779588839 @default.
- W3119072885 cites W1832844068 @default.
- W3119072885 cites W1965850868 @default.
- W3119072885 cites W2021377837 @default.
- W3119072885 cites W2026092903 @default.
- W3119072885 cites W2039123767 @default.
- W3119072885 cites W2041680367 @default.
- W3119072885 cites W2046161326 @default.
- W3119072885 cites W2048073154 @default.
- W3119072885 cites W2048424790 @default.
- W3119072885 cites W2062889582 @default.
- W3119072885 cites W2063497807 @default.
- W3119072885 cites W2069272114 @default.
- W3119072885 cites W2070198274 @default.
- W3119072885 cites W2075834529 @default.
- W3119072885 cites W2080641261 @default.
- W3119072885 cites W2089446672 @default.
- W3119072885 cites W2108813072 @default.
- W3119072885 cites W2118471749 @default.
- W3119072885 cites W2119896120 @default.
- W3119072885 cites W2124220652 @default.
- W3119072885 cites W2128758225 @default.
- W3119072885 cites W2140875987 @default.
- W3119072885 cites W2143163879 @default.
- W3119072885 cites W2143772132 @default.
- W3119072885 cites W2166662937 @default.
- W3119072885 cites W2189073727 @default.
- W3119072885 cites W2766122192 @default.
- W3119072885 cites W2767931551 @default.
- W3119072885 cites W2780534461 @default.
- W3119072885 cites W2808731493 @default.
- W3119072885 cites W2808909747 @default.
- W3119072885 cites W3011093503 @default.
- W3119072885 cites W3037202317 @default.
- W3119072885 cites W3095323850 @default.
- W3119072885 doi "https://doi.org/10.1136/jitc-2020-001660" @default.
- W3119072885 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7812096" @default.
- W3119072885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33441389" @default.
- W3119072885 hasPublicationYear "2021" @default.
- W3119072885 type Work @default.
- W3119072885 sameAs 3119072885 @default.
- W3119072885 citedByCount "10" @default.
- W3119072885 countsByYear W31190728852021 @default.
- W3119072885 countsByYear W31190728852022 @default.
- W3119072885 countsByYear W31190728852023 @default.
- W3119072885 crossrefType "journal-article" @default.
- W3119072885 hasAuthorship W3119072885A5000430747 @default.
- W3119072885 hasAuthorship W3119072885A5016924764 @default.
- W3119072885 hasAuthorship W3119072885A5018760297 @default.
- W3119072885 hasAuthorship W3119072885A5030616197 @default.
- W3119072885 hasAuthorship W3119072885A5039290647 @default.
- W3119072885 hasAuthorship W3119072885A5050472627 @default.
- W3119072885 hasAuthorship W3119072885A5069800223 @default.
- W3119072885 hasAuthorship W3119072885A5072030436 @default.
- W3119072885 hasAuthorship W3119072885A5081250941 @default.
- W3119072885 hasAuthorship W3119072885A5084135240 @default.
- W3119072885 hasAuthorship W3119072885A5090423715 @default.
- W3119072885 hasBestOaLocation W31190728851 @default.
- W3119072885 hasConcept C154317977 @default.
- W3119072885 hasConcept C159654299 @default.
- W3119072885 hasConcept C164027704 @default.
- W3119072885 hasConcept C17991360 @default.
- W3119072885 hasConcept C202751555 @default.
- W3119072885 hasConcept C203014093 @default.
- W3119072885 hasConcept C2776914184 @default.
- W3119072885 hasConcept C2777701055 @default.
- W3119072885 hasConcept C2778690821 @default.
- W3119072885 hasConcept C2780851360 @default.
- W3119072885 hasConcept C502942594 @default.
- W3119072885 hasConcept C522857546 @default.
- W3119072885 hasConcept C55493867 @default.
- W3119072885 hasConcept C71924100 @default.
- W3119072885 hasConcept C86803240 @default.
- W3119072885 hasConcept C8891405 @default.
- W3119072885 hasConcept C95444343 @default.
- W3119072885 hasConceptScore W3119072885C154317977 @default.
- W3119072885 hasConceptScore W3119072885C159654299 @default.
- W3119072885 hasConceptScore W3119072885C164027704 @default.
- W3119072885 hasConceptScore W3119072885C17991360 @default.
- W3119072885 hasConceptScore W3119072885C202751555 @default.
- W3119072885 hasConceptScore W3119072885C203014093 @default.
- W3119072885 hasConceptScore W3119072885C2776914184 @default.